Comparing commercial pharmacogenetic testing results and recommendations for antidepressants with established CPIC guidelines

Comparing commercial pharmacogenetic testing results and recommendations for antidepressants with established CPIC guidelines

IntroductionIncreasingly, pharmacogenetic testing helps providers with medication selection based upon patient-specific DNA results. While several government-funded organizations work towards consensus and standardization for testing and interpretation, compliance to these best practices remains inc...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tiffany T. Nguyen, Emili J. W. Leary, Joshua T. Lee, Sanjay K. Shukla, Sara A. Griesbach
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Series:	Frontiers in Pharmacology
Subjects:	pharmacogenomics pharmacogenetic testing results pharmacogenetic testing company binning pharmacogenetics pharmacogenetic testing
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1500235/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Insights in pharmacogenetics and pharmacogenomics: 2023
by: José A. G. Agúndez, et al.
Published: (2025-01-01)

Applied pharmacogenetics to predict response to treatment of first psychotic episode: study protocol
by: Sergi Mas, et al.
Published: (2025-01-01)

Pharmacogenomic profiling of the South Korean population: Insights and implications for personalized medicine
by: Mi Seon Youn, et al.
Published: (2024-12-01)

Pharmacogenetics of colorectal cancer in a third-level hospital in Valencia
by: Comes-Raga Ana, et al.
Published: (2024-11-01)

Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic Biomarkers
by: Andrea Rodríguez-Lopez, et al.
Published: (2024-12-01)

Pharmacogenetic markers of colorectal cancer treatment. New approaches for cytostatic drugs efficacy estimation
by: N. B. Zakharzhevskaya, et al.
Published: (2015-12-01)

Influence of ABCB1 polymorphisms on aripiprazole and dehydroaripiprazole plasma concentrations
by: Francisco José Toja-Camba, et al.
Published: (2025-01-01)

PEG-Interferon-α ribavirin-induced HCV viral clearance: a pharmacogenetic multicenter Spanish study
by: Javier Milara, et al.
Published: (2015-01-01)

Validation of genetic polymorphisms associated to the toxicity of chemotherapy in colorectal cancer patients
by: L. Cortejoso, et al.
Published: (2014-07-01)

Insights from Bibliometric Analysis of Epilepsy Research in Morocco between 1969 and 2024
by: Abdelaziz Zennati, et al.
Published: (2024-09-01)

Pharmacogenetics: Influence of CYP2C9*2 and *3 alleles polymorphisms on Iraqi type 2 diabetic patients
by: Ghada S. Rasool, et al.
Published: (2024-01-01)

Corrigendum: Review of adult gender transition medications: mechanisms, efficacy measures, and pharmacogenomic considerations
by: Inder Sehgal
Published: (2025-01-01)

Review of adult gender transition medications: mechanisms, efficacy measures, and pharmacogenomic considerations
by: Inder Sehgal
Published: (2023-07-01)

Pharmacogenomics predictors of aromatic antiepileptic drugs-induced SCARs in the Iraqi patients
by: Ali Fadhel Ahmed, et al.
Published: (2025-01-01)

The Frequency of <i>DPYD</i> c.557A>G in the Dominican Population and Its Association with African Ancestry
by: Mariela Guevara, et al.
Published: (2024-12-01)

Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences
by: Muriel Javier, et al.
Published: (2023-06-01)

GWAS of CRP response to statins further supports the role of APOE in statin response: A GIST consortium study
by: Emma F. Magavern, et al.
Published: (2025-02-01)

Integration of pharmacogenetic data in epic genomic module drives clinical decision support alerts
by: Kimberly J. Newsom, et al.
Published: (2024-12-01)

MORE ATTENTION TO QUALITY OF PHARMACOTHERAPY IN PSYCHIATRY
by: ERKKI ISOMETSÄ
Published: (2024-11-01)

Impact of donor CYP3A5 genotype on pharmacokinetics of tacrolimus in South African paediatric liver transplant patients
by: C Wheeler, et al.
Published: (2024-04-01)

Pharmacogenotyping disproves genetic cause of drug-related problems in family history: a case report
by: Anna Bollinger, et al.
Published: (2024-11-01)

Associations between (pharmaco-)genetic markers and postoperative pain after inguinal hernia repair – a prospective study protocol
by: Florine M. Wiss, et al.
Published: (2024-12-01)

AKR1D1*36 C>T (rs1872930) allelic variant is associated with variability of the CYP2C9 genotype predicted pharmacokinetics of ibuprofen enantiomers – a pilot study in healthy volunteers
by: Kapedanovska Nestorovska Aleksandra, et al.
Published: (2019-09-01)

DPYD variant testing in candidates for fluoropyrimidine treatment: A study protocol
by: Ana Hernández-Guío, et al.
Published: (2021-05-01)

Liquid biopsy: an innovative and reliable method for detecting not only somatic, but also germline mutations in patients with colorectal and non-small cell lung carcinoma
by: Nelly Miteva-Marcheva, et al.
Published: (2023-03-01)

Development and validation of a next-generation sequencing panel for clinical pharmacogenetics
by: Luis Ramudo-Cela, et al.
Published: (2020-11-01)

Treatment and Genotypic Characteristics of Patients with Rheumatoid Arthritis
by: Norbutoev Olimjon, et al.
Published: (2025-01-01)

UGT1A1*28 polymorphism and the risk of toxicity and disease progression in patients with breast cancer receiving sacituzumab govitecan
by: Megan H. Wong, et al.
Published: (2024-08-01)

Analysis of depression in Brazil and the feasibility of incorporating pharmacogenomics as an auxiliary tool in antidepressant treatment
by: Rafaela Slaviero Pinheiro Cerdeira, et al.
Published: (2025-01-01)

Exploring the preparedness of hospital pharmacists practising in Southwest London for implementing pharmacogenomics testing
by: Thuy Mason, et al.
Published: (2024-12-01)

Editorial: Pharmacogenetics of psychiatric disorders
by: Sarah Allegra, et al.
Published: (2025-01-01)

The Role of Pharmacogenetic-Based Pharmacokinetic Analysis in Precise Breast Cancer Treatment
by: Xinyu Wu, et al.
Published: (2024-10-01)

Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol
by: Juliana Salazar, et al.
Published: (2024-12-01)

Bridging the gap: understanding the perspective of healthcare professional students towards precision medicine in a Nigerian tertiary institution (a cross-sectional study)
by: Ezinwanne Jane Ugochukwu, et al.
Published: (2025-01-01)

Effects of pharmacogenomics-guided treatment on medication adherence and the antidepressant switching rate in major depressive disorder
by: Chaoli Chen, et al.
Published: (2024-11-01)

THE PROBLEMS OF QUALITY EMPIRICAL RESEARCH
by: M. Yurasova
Published: (2016-11-01)

Optimization of antidepressant treatment by pharmacogenomics: a case report
by: Ying Zhang, et al.
Published: (2025-01-01)

Integrating pharmacogenetics, multi‐omics and machine learning in the novel therapeutic view of pulmonary hypertension
by: Chenxi Li, et al.
Published: (2025-01-01)

Assessment of Antidepressant Activity of Ethanolic Extract of Hibiscus rosa sinensis Linn. Petals in Comparison with Fluoxetine and its Toxicity in Swiss Albino Mice: A Preclinical Research Protocol
by: Sneha Ray, et al.
Published: (2024-12-01)

Assessing the effectiveness of using electronic distance learning methods and the relationship with the results of the Bennett and Unified State Exam tests
by: Maksim S. Ivanov, et al.
Published: (2024-12-01)